Medipacs Logo Medipacs header
Home About Us About Us Products Investors Newsroom Technology Medipacs
Header bottom
 
 
Infusion Market
Over one million drug infusions are performed daily in the U.S.
Growth rate is estimated at 13% through 2010.
 Contact us

Medipacs
9040 S. Rita Rd. Ste. 2250
Tucson, AZ 85747
(520)382-3264
email: info@medipacs.com

 

Medipacs has been selected as a finalist for the 2005 Governor's Celebration of Innovation Awards.

News Release
September 18, 2005

The Arizona Technology council announced today that Medipacs, a Tucson biotech company, has been selected as a finalist for Innovator of the year-start up company.

The Medipacs application is for a market of over ONE MILLION INFUSIONS that happen every day in the United States .

Medipacs recently unveiled the first Digital Pump TM and is now focusing on its first commercial application, a programmable disposable infusion pump. The Medipacs proprietary pump technology known as pulse activated cell systems, (PACS) uses electrically activated polymers in a computer controlled environment that eliminates the need for electric motors and pump mechanisms.

The Master of Ceremonies , Governor Janet Napolitano , will honor this years finalists at the Arizona Biltmore Resort in Phoenix on November 15, 2005 .

"With over 100 submissions, the selection committee had a laborious task in narrowing the finalists down," says Stephanie Vial with the Arizona Technology Council.

The Governor's Celebration of Innovation is the largest statewide awards gathering of technology companies in Arizona . It delivers an insider look at emerging to established companies showing off cutting - edge innovations.

Medipacs Company Contact:

Laurie Hassey lhassey@medipacs.com

Public Relations (520) 382-3264

This news release may contain forward looking information. Actual future results may differ materially from those contemplated. The risks, uncertainties and other factors, both known & unknown, could influence actual results may be substantial & include those described in documents filed with regulatory authorities. No assurances can be given that any of the events anticipated by the forward looking statements will transpire or occur, or if any of them do so, what benefits the company will derive therefrom.

 

 
   
  All materials copyright
Medipacs® 2004